BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 21151896)

  • 1. Genomic aberrations in lung adenocarcinoma in never smokers.
    Job B; Bernheim A; Beau-Faller M; Camilleri-Broët S; Girard P; Hofman P; Mazières J; Toujani S; Lacroix L; Laffaire J; Dessen P; Fouret P;
    PLoS One; 2010 Dec; 5(12):e15145. PubMed ID: 21151896
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Lung adenocarcinoma of never smokers and smokers harbor differential regions of genetic alteration and exhibit different levels of genomic instability.
    Thu KL; Vucic EA; Chari R; Zhang W; Lockwood WW; English JC; Fu R; Wang P; Feng Z; MacAulay CE; Gazdar AF; Lam S; Lam WL
    PLoS One; 2012; 7(3):e33003. PubMed ID: 22412972
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genomic and transcriptional alterations in lung adenocarcinoma in relation to EGFR and KRAS mutation status.
    Planck M; Edlund K; Botling J; Micke P; Isaksson S; Staaf J
    PLoS One; 2013; 8(10):e78614. PubMed ID: 24205279
    [TBL] [Abstract][Full Text] [Related]  

  • 4. High-resolution detection of recurrent aberrations in lung adenocarcinomas by array comparative genomic hybridization and expression analysis of selective genes by quantitative PCR.
    Zhu H; Wong MP; Tin V
    Int J Oncol; 2014 Jun; 44(6):2068-76. PubMed ID: 24728343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chromosomal aberrations of malignant pleural effusions of lung adenocarcinoma: different cytogenetic changes are correlated with genders and smoking habits.
    Yen CC; Liang SC; Jong YJ; Chen YJ; Lin CH; Chen YM; Wu YC; Su WC; Huang CY; Tseng SW; Whang-Peng J
    Lung Cancer; 2007 Sep; 57(3):292-301. PubMed ID: 17553591
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chromosomal aberrations of primary lung adenocarcinomas in nonsmokers.
    Wong MP; Fung LF; Wang E; Chow WS; Chiu SW; Lam WK; Ho KK; Ma ES; Wan TS; Chung LP
    Cancer; 2003 Mar; 97(5):1263-70. PubMed ID: 12599234
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Copy number gains on 5p15, 6p11-q11, 7p12, and 8q24 are rare in sputum cells of individuals at high risk of lung cancer.
    Kettunen E; Salmenkivi K; Vuopala K; Toljamo T; Kuosma E; Norppa H; Knuutila S; Kaleva S; Huuskonen MS; Anttila S
    Lung Cancer; 2006 Nov; 54(2):169-76. PubMed ID: 16935392
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High-resolution genomic profiling reveals association of chromosomal aberrations on 1q and 16p with histologic and genetic subgroups of invasive breast cancer.
    Stange DE; Radlwimmer B; Schubert F; Traub F; Pich A; Toedt G; Mendrzyk F; Lehmann U; Eils R; Kreipe H; Lichter P
    Clin Cancer Res; 2006 Jan; 12(2):345-52. PubMed ID: 16428471
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between smoking history and gene expression profiles in lung adenocarcinomas.
    Staaf J; Jönsson G; Jönsson M; Karlsson A; Isaksson S; Salomonsson A; Pettersson HM; Soller M; Ewers SB; Johansson L; Jönsson P; Planck M
    BMC Med Genomics; 2012 Jun; 5():22. PubMed ID: 22676229
    [TBL] [Abstract][Full Text] [Related]  

  • 10. DNA copy number changes and evaluation of MYC, IGF1R, and FES amplification in xenografts of pancreatic adenocarcinoma.
    Armengol G; Knuutila S; Lluís F; Capellà G; Miró R; Caballín MR
    Cancer Genet Cytogenet; 2000 Jan; 116(2):133-41. PubMed ID: 10640145
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Genetic classification of lung adenocarcinoma based on array-based comparative genomic hybridization analysis: its association with clinicopathologic features.
    Shibata T; Uryu S; Kokubu A; Hosoda F; Ohki M; Sakiyama T; Matsuno Y; Tsuchiya R; Kanai Y; Kondo T; Imoto I; Inazawa J; Hirohashi S
    Clin Cancer Res; 2005 Sep; 11(17):6177-85. PubMed ID: 16144918
    [TBL] [Abstract][Full Text] [Related]  

  • 12. An integrated genomic analysis of lung cancer reveals loss of DUSP4 in EGFR-mutant tumors.
    Chitale D; Gong Y; Taylor BS; Broderick S; Brennan C; Somwar R; Golas B; Wang L; Motoi N; Szoke J; Reinersman JM; Major J; Sander C; Seshan VE; Zakowski MF; Rusch V; Pao W; Gerald W; Ladanyi M
    Oncogene; 2009 Aug; 28(31):2773-83. PubMed ID: 19525976
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Integrative analysis of array-comparative genomic hybridisation and matched gene expression profiling data reveals novel genes with prognostic significance in oesophageal adenocarcinoma.
    Goh XY; Rees JR; Paterson AL; Chin SF; Marioni JC; Save V; O'Donovan M; Eijk PP; Alderson D; Ylstra B; Caldas C; Fitzgerald RC
    Gut; 2011 Oct; 60(10):1317-26. PubMed ID: 21478220
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chromosomal alterations in lung adenocarcinoma from smokers and nonsmokers.
    Sanchez-Cespedes M; Ahrendt SA; Piantadosi S; Rosell R; Monzo M; Wu L; Westra WH; Yang SC; Jen J; Sidransky D
    Cancer Res; 2001 Feb; 61(4):1309-13. PubMed ID: 11245426
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Genomic and transcriptional alterations in lung adenocarcinoma in relation to smoking history.
    Karlsson A; Ringnér M; Lauss M; Botling J; Micke P; Planck M; Staaf J
    Clin Cancer Res; 2014 Sep; 20(18):4912-24. PubMed ID: 25037737
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Genomic alterations in lung adenocarcinomas detected by multicolor fluorescence in situ hybridization and comparative genomic hybridization.
    Shen H; Zhu Y; Wu YJ; Qiu HR; Shu YQ
    Cancer Genet Cytogenet; 2008 Mar; 181(2):100-7. PubMed ID: 18295661
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Abnormalities of the TITF-1 lineage-specific oncogene in NSCLC: implications in lung cancer pathogenesis and prognosis.
    Tang X; Kadara H; Behrens C; Liu DD; Xiao Y; Rice D; Gazdar AF; Fujimoto J; Moran C; Varella-Garcia M; Lee JJ; Hong WK; Wistuba II
    Clin Cancer Res; 2011 Apr; 17(8):2434-43. PubMed ID: 21257719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identifying the Appropriate FISH Criteria for Defining MET Copy Number-Driven Lung Adenocarcinoma through Oncogene Overlap Analysis.
    Noonan SA; Berry L; Lu X; Gao D; Barón AE; Chesnut P; Sheren J; Aisner DL; Merrick D; Doebele RC; Varella-Garcia M; Camidge DR
    J Thorac Oncol; 2016 Aug; 11(8):1293-1304. PubMed ID: 27262212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clustered genomic alterations in chromosome 7p dictate outcomes and targeted treatment responses of lung adenocarcinoma with EGFR-activating mutations.
    Yuan S; Yu SL; Chen HY; Hsu YC; Su KY; Chen HW; Chen CY; Yu CJ; Shih JY; Chang YL; Cheng CL; Hsu CP; Hsia JY; Lin CY; Wu G; Liu CH; Wang CD; Yang KC; Chen YW; Lai YL; Hsu CC; Lin TC; Yang TY; Chen KC; Hsu KH; Chen JJ; Chang GC; Li KC; Yang PC
    J Clin Oncol; 2011 Sep; 29(25):3435-42. PubMed ID: 21810691
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Patterns of chromosomal copy-number alterations in intrahepatic cholangiocarcinoma.
    Dalmasso C; Carpentier W; Guettier C; Camilleri-Broët S; Borelli WV; Campos Dos Santos CR; Castaing D; Duclos-Vallée JC; Broët P
    BMC Cancer; 2015 Mar; 15():126. PubMed ID: 25879652
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.